Vertebral Fusion Clinical Trial
Official title:
"Randomized Evaluation of Bone Ingrowth After Intervertebral Body Fusion With Either MectaLIF® PEEK or MectaLIF® TiPEEK Oblique"
Verified date | February 2017 |
Source | Johann Wolfgang Goethe University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Clinical outcome with regard to oswestry disability index and lumbar fusion rate after implantation of titanium coated PEEK cage and common PEEK cage
Status | Completed |
Enrollment | 40 |
Est. completion date | December 1, 2013 |
Est. primary completion date | September 1, 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Persistence of - low back pain, - sciatica and - spinal claudication after conservative treatment attributed to L3 to L5 lumbar segments. Exclusion Criteria: - previous lumbar spinal surgery - body mass index >35 kg/m² |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Mohammad ARAB MOTLAGH |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical outcome assessed by Oswestry Disability Index (ODI) after instrumented transforaminal lumbar fusion with TiPEEK or common PEEK | Oswestry Disability Index (ODI) after instrumented transforaminal lumbar fusion with TiPEEK or common PEEK | 12 months | |
Secondary | Fusion result | Fusion rate after instrumented transforaminal lumbar fusion with TiPEEK or common PEEK | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06367933 -
Mini-invasive Spine Surgery for Neuromuscolar Scoliosis
|
N/A |